Treatment of BRL 28500 (clavulanic acid-ticarcillin) for infections in patients with hematological diseases

Chemical Compounds

• Ticarcillin 100%
• Clavulanic Acid 85%
• Haematological 80%
• Dose 43%

Medicine & Life Sciences

• ticarcillin-clavulanic acid 91%
• Hematologic Diseases 65%
• Infections 26%
• Sepsis 22%
• Intravenous Infusions 18%
• Ticarcillin 13%
• Clavulanic Acid 12%
• Cellulitis 11%
• Therapeutics 9%
• Pneumonia 7%